Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 31 Prostatic Hyperplasia 5 Neoplasms 4 Urinary Bladder Neoplasms 1 Recurrence 1 Neoplasm Metastasis 1 Lower Urinary Tract Symptoms 1 Erectile Dysfunction 1 Adenocarcinoma of the Prostate 1

Interventions

Peripheral Blood Stem Cell Transplantation 6 Cyclophosphamide 6 fludarabine phosphate 5 Nivolumab 5 Mycophenolic Acid 5 Carboplatin 5 Whole-Body Irradiation 4 Radiotherapy 4 Filgrastim 4 Cyclosporine 4 Gemcitabine 3 Cisplatin 3 Busulfan 3 Antilymphocyte Serum 3 cabozantinib 2 cabazitaxel 2 Voriconazole 2 Thiotepa 2 Therapeutics 2 Standard of Care 2 Sirolimus 2 Polymerase Chain Reaction 2 Mitomycin 2 Methylprednisolone 2 Methotrexate 2 Melphalan 2 Itraconazole 2 Immunoglobulin G 2 Goserelin 2 Flow Cytometry 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Dutasteride × Genitourinary × Clear all

NCT07420517 2026-03-30

DutaBCa-1

CHU de Quebec-Universite Laval

Phase 2 Recruiting

Urinary Bladder Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡